254 related articles for article (PubMed ID: 33512410)
1. How I treat cold agglutinin disease.
Berentsen S
Blood; 2021 Mar; 137(10):1295-1303. PubMed ID: 33512410
[TBL] [Abstract][Full Text] [Related]
2. Current Treatment Options in Cold Agglutinin Disease: B-Cell Directed or Complement Directed Therapy?
Berentsen S; Tjønnfjord GE
Transfus Med Rev; 2022 Oct; 36(4):181-187. PubMed ID: 36127205
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune hemolytic anemia.
Hill A; Hill QA
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):382-389. PubMed ID: 30504336
[TBL] [Abstract][Full Text] [Related]
4. Cold agglutinin disease.
Berentsen S
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):226-231. PubMed ID: 27913484
[TBL] [Abstract][Full Text] [Related]
5. How I manage patients with cold agglutinin disease.
Berentsen S
Br J Haematol; 2018 May; 181(3):320-330. PubMed ID: 29363757
[TBL] [Abstract][Full Text] [Related]
6. Sutimlimab for treatment of cold agglutinin disease: why, how and for whom?
Berentsen S; Barcellini W; D'Sa S; Jilma B
Immunotherapy; 2022 Oct; 14(15):1191-1204. PubMed ID: 35946351
[TBL] [Abstract][Full Text] [Related]
7. Sutimlimab: A Complement C1s Inhibitor for the Management of Cold Agglutinin Disease-Associated Hemolysis.
Moore DC; Arnall JR
Ann Pharmacother; 2023 Aug; 57(8):970-977. PubMed ID: 36476151
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial.
Jäger U; D'Sa S; Schörgenhofer C; Bartko J; Derhaschnig U; Sillaber C; Jilma-Stohlawetz P; Fillitz M; Schenk T; Patou G; Panicker S; Parry GC; Gilbert JC; Jilma B
Blood; 2019 Feb; 133(9):893-901. PubMed ID: 30559259
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies for treatment of cold agglutinin disease.
Gelbenegger G; Berentsen S; Jilma B
Expert Opin Biol Ther; 2023 May; 23(5):395-406. PubMed ID: 37128907
[TBL] [Abstract][Full Text] [Related]
10. Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial.
Berentsen S; Randen U; Oksman M; Birgens H; Tvedt THA; Dalgaard J; Galteland E; Haukås E; Brudevold R; Sørbø JH; Næss IA; Malecka A; Tjønnfjord GE
Blood; 2017 Jul; 130(4):537-541. PubMed ID: 28533306
[TBL] [Abstract][Full Text] [Related]
11. Complement-directed therapy for cold agglutinin disease: sutimlimab.
Broome CM
Expert Rev Hematol; 2023; 16(7):479-494. PubMed ID: 37256550
[TBL] [Abstract][Full Text] [Related]
12. [Sutimlimab for cold agglutinin disease, a newcomer among complement inhibitors in immunohematology].
Michel M
Rev Med Interne; 2024 May; 45(5):255-257. PubMed ID: 38719668
[No Abstract] [Full Text] [Related]
13. Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery.
Tvedt THA; Steien E; Øvrebø B; Haaverstad R; Hobbs W; Wardęcki M; Tjønnfjord GE; Berentsen SA
Am J Hematol; 2022 Feb; 97(2):E51-E54. PubMed ID: 34778998
[No Abstract] [Full Text] [Related]
14. Antibody based therapeutics for autoimmune hemolytic anemia.
Cavallaro F; Barcellini W; Fattizzo B
Expert Opin Biol Ther; 2023; 23(12):1227-1237. PubMed ID: 37874225
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program.
Gelbenegger G; Schoergenhofer C; Derhaschnig U; Buchtele N; Sillaber C; Fillitz M; Schenk TM; D'Sa S; Cartwright R; Gilbert JC; Jilma B; Jaeger U
Blood Adv; 2020 Mar; 4(6):997-1005. PubMed ID: 32176765
[TBL] [Abstract][Full Text] [Related]
16. Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases.
Eren R; Suyanı E
Turk J Haematol; 2018 Nov; 35(4):312-313. PubMed ID: 29983407
[No Abstract] [Full Text] [Related]
17. [Cold agglutinin disease - no response to glucocorticoids and rituximab, what treatment is best for the 3rd line of therapy? Case report and review of the literature].
Adam Z; Pejchalová A; Chlupová G; Ríhová L; Pour L; Krejčí M; Cervinek L; Král Z; Mayer J
Vnitr Lek; 2013 Sep; 59(9):828-40. PubMed ID: 24073955
[TBL] [Abstract][Full Text] [Related]
18. Updates on the Diagnosis and Management of Cold Autoimmune Hemolytic Anemia.
Gertz MA
Hematol Oncol Clin North Am; 2022 Apr; 36(2):341-352. PubMed ID: 35282954
[TBL] [Abstract][Full Text] [Related]
19. Sutimlimab in Cold Agglutinin Disease.
Röth A; Barcellini W; D'Sa S; Miyakawa Y; Broome CM; Michel M; Kuter DJ; Jilma B; Tvedt THA; Fruebis J; Jiang X; Lin S; Reuter C; Morales-Arias J; Hobbs W; Berentsen S
N Engl J Med; 2021 Apr; 384(14):1323-1334. PubMed ID: 33826820
[TBL] [Abstract][Full Text] [Related]
20. Introduction to a How I Treat series on acquired hemolytic anemia.
Cazzola M
Blood; 2021 Mar; 137(10):1269. PubMed ID: 33512433
[No Abstract] [Full Text] [Related]
[Next] [New Search]
